Galidesivir
(2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol
Molecular Identity
Galidesivir
(2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol
PubChem CID: 10445549
2D Structure
Properties
C11H15N5O3
Molecular Formula
265.27
Molecular Weight
g/mol
265.1175
Exact Mass
Da
-2.1
XLogP
Drug-like (Lipinski: < 5)
140
TPSA
May have limited oral absorption
6
H-Bond Donors
7
H-Bond Acceptors
333
Complexity
SMILES
Canonical SMILES
SMILES: C1=C(C2=C(N1)C(=NC=N2)N)C3C(C(C(N3)CO)O)OIsomeric SMILES
SMILES: C1=C(C2=C(N1)C(=NC=N2)N)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)OSynonyms(20)
Galidesivir249503-25-1IMMUCILLIN AImmucillin-ABCX4430(2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diolImmA cpdOLF97F86A73,4-PYRROLIDINEDIOL, 2-(4-AMINO-5H-PYRROLO(3,2-D)PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)-, (2S,3S,4R,5R)-DTXSID0010280392-(4-Amino-5H-pyrrolo(3,2-d)pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diolgalidesivirum(2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo(3,2-d)pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diolRefChem:142164DTXCID001513602
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Galidesivir
Loading drug network...